Has Anthony Hart, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,722 in general payments to Anthony Hart, MD across 88 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anthony Hart, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anthony Hart, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anthony Hart, MD

Interventional Cardiology · Kansas City, MONPI 1508088766

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Medtronic at 33.3% of the total. That places this record below the midpoint for interventional cardiology clinicians in MO, where the typical reported total is $10,448.

$6,722in general payments, 2019–2025

Across 88 payments — averaging $76.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$2K
Abbott$1K
Boston Scientific$1K
Edwards Lifesciences$812
Shockwave Medical, Inc$441
Abiomed$307
plus $394 from 6 others

$195,185in research payments, 2019–2025

Across 28 payments — averaging $6970.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Shockwave Medical, Inc$142K
Abbott$42K
Novartis$11K

What the payments were for

Food & beverage$6,702100%
Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	27	$2,236
Abbott	23	$1,272
Boston Scientific	12	$1,259
Edwards Lifesciences	10	$812
Shockwave Medical, Inc	5	$441
Abiomed	3	$307
Teleflex LLC	1	$144
Biocardia, Inc.	1	$105
Penumbra, Inc.	2	$68
Asahi Intecc USA, Inc.	2	$41
CSL Behring	1	$20
Livanova USA, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,722 in reported general payments places this provider in the 40th percentile of 182 interventional cardiology providers in Missouri.

See all interventional cardiology providers in Missouri →

Medicare billing

Part B allowed, 2024

$142,815

Medicare patients

688

Services billed

1,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	275	$271,447
JardianceEmpagliflozin	121	$123,711
XareltoRivaroxaban	73	$72,850
Repatha SureclickEvolocumab	60	$68,274
OzempicSemaglutide	34	$32,127
Praluent PenAlirocumab	25	$27,706
EntrestoSacubitril/Valsartan	18	$19,843
Atorvastatin Calcium	386	$4,223
Rosuvastatin Calcium	302	$4,082
Carvedilol	290	$2,740
Metoprolol Succinate	206	$2,421
Amlodipine Besylate	429	$2,311
Losartan Potassium	252	$2,241
Ezetimibe	115	$2,139
Diltiazem 24hr Er (Cd)Diltiazem Hcl	80	$1,507

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Kansas City

Gerald MancusoKansas City$402K
James GranthamKansas City$357K
Matthew BunteKansas City$242K
Adnan ChhatriwallaKansas City$114K
Kenneth HuberKansas City$110K
Chetan HudedKansas City$61K
Adam SalisburyKansas City$52K
Steven MarsoKansas City$42K
Dany JacobKansas City$35K
Muhammad Anis HaiderKansas City$35K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →